Skip to main content
TipRanks
Go Ultimate75% OFF

Devyser Diagnostics AB (DVYSR) Stock Statistics & Valuation Metrics

1 Followers

Total Valuation

Devyser Diagnostics AB has a market cap or net worth of SEK 1.07B. The enterprise value is SEK 813.30M.

Market Cap
SEK 1.07B
Enterprise Value
SEK 813.30M

Share Statistics

Devyser Diagnostics AB has 16,889,807 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
16,889,807
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

Devyser Diagnostics AB’s return on equity (ROE) is -0.02 and return on invested capital (ROIC) is 2.57%.

Return on Equity (ROE)
-0.02
Return on Assets (ROA)
-0.02
Return on Invested Capital (ROIC)
2.57%
Return on Capital Employed (ROCE)
0.03
Revenue Per Employee
2.26M
Profits Per Employee
-75.68K
Employee Count
111
Asset Turnover
0.53
Inventory Turnover
1.31

Valuation Ratios

The current PE Ratio of Devyser Diagnostics AB is 41.51. Devyser Diagnostics AB’s PEG ratio is 0.04.

PE Ratio
41.51
PS Ratio
4.20
PB Ratio
2.74
Price to FCF
24.61
Price to Operating Cash Flow
18.34
PEG Ratio
0.04

Income Statement

In the last 12 months, Devyser Diagnostics AB had revenue of 250.50M and earned -8.40M in profits. Earnings per share was -0.51.

Revenue
250.50M
Gross Profit
201.90M
Operating Income
10.60M
Pretax Income
-2.60M
Net Income
-8.40M
EBITDA
37.70M
Earnings Per Share (EPS)
-0.51

Cash Flow

In the last 12 months, operating cash flow was 58.10M and capital expenditures -30.40M, giving a free cash flow of 43.30M billion.

Operating Cash Flow
58.10M
Free Cash Flow
43.30M
Free Cash Flow per Share
2.56

Dividends & Yields

Devyser Diagnostics AB pays an annual dividend of ―, resulting in a dividend yield of ―

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
4.06%
Earnings Yield
2.38%

Stock Price Statistics

Beta
0.57
52-Week Price Change
-42.64%
50-Day Moving Average
55.55
200-Day Moving Average
74.21
Relative Strength Index (RSI)
57.04
Average Volume (3m)
19.05K

Important Dates

Devyser Diagnostics AB upcoming earnings date is Feb 16, 2027, Before Open (Not Confirmed).

Last Earnings Date
Nov 03, 2026
Next Earnings Date
Feb 16, 2027
Ex-Dividend Date
―

Financial Position

Devyser Diagnostics AB as a current ratio of 2.88, with Debt / Equity ratio of 14.65%

Current Ratio
2.88
Quick Ratio
2.36
Debt to Market Cap
0.00
Net Debt to EBITDA
-0.68
Interest Coverage Ratio
0.78

Taxes

In the past 12 months, Devyser Diagnostics AB has paid 5.80M in taxes.

Income Tax
5.80M
Effective Tax Rate
-2.23

Enterprise Valuation

Devyser Diagnostics AB EV to EBITDA ratio is 17.85, with an EV/FCF ratio of 23.58.

EV to Sales
4.02
EV to EBITDA
17.85
EV to Free Cash Flow
23.58
EV to Operating Cash Flow
17.57

Balance Sheet

Devyser Diagnostics AB has SEK 88.70M in cash and marketable securities with SEK 44.00M in debt, giving a net cash position of SEK 44.70M billion.

Cash & Marketable Securities
SEK 88.70M
Total Debt
SEK 44.00M
Net Cash
SEK 44.70M
Net Cash Per Share
SEK 2.65
Tangible Book Value Per Share
SEK 11.12

Margins

Gross margin is 80.06%, with operating margin of 11.04%, and net profit margin of 10.01%.

Gross Margin
80.06%
Operating Margin
11.04%
Pretax Margin
12.10%
Net Profit Margin
10.01%
EBITDA Margin
22.55%
EBIT Margin
11.79%

Analyst Forecast

The average price target for Devyser Diagnostics AB is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
4.49%
EPS Growth Forecast
―

Scores

Smart Score
―
AI Score
64